Cite
APA Citation
Wang, R., Lin, W., Lin, C., Li, L., Sun, Y., & Chang, C. (2016). aSC-J9® suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L. Cancer letters, 379(1), 154–160. http://access.bl.uk/ark:/81055/vdc_100034056397.0x00004c